-
G007-LK: Tankyrase 1/2 Inhibitor Workflows
2026-08-27
G007-LK turns tankyrase biology into a practical workflow for measuring Wnt/β-catenin pathway inhibition, β-catenin degradation induction, and tumor-cell growth phenotypes. Its value is greatest when reporter, protein, and long-term proliferation assays are combined rather than interpreted from viability data alone.
-
HyperPFU™ high-fidelity DNA polymerase Guide
2026-08-27
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is suitable for blunt-ended cloning and sequencing workflows, but not for protocols that require 3′-A overhangs or preformed sticky ends.
-
HOBt for Peptide and Medicinal Chemistry Workflows
2026-08-26
HOBt supports high-fidelity amide bond formation when stereochemical control and mild activation are important. This practical guide connects peptide synthesis with the modular medicinal-chemistry workflow used to develop indazole- and indole-based glucagon receptor antagonists.
-
Mifepristone (RU486): Receptor-Aware Assays
2026-08-26
Mifepristone (RU486) is more than a progesterone receptor antagonist: it is a valuable perturbation tool for dissecting hormone-dependent phenotypes. This guide connects oncology and reproductive assays with tissue-specific nuclear receptor biology and practical controls.
-
BAF53a, EMT, and Glioma Prognosis
2026-08-25
Meng et al. identify BAF53a as a prognostic biomarker associated with overall and progression-free survival in glioma and show that altering BAF53a levels changes glioma-cell proliferation, motility, invasion, and EMT-associated marker expression. The study provides a useful mechanistic hypothesis linking a chromatin-remodeling complex subunit with aggressive glioma behavior, while its retrospective cohort and single-cell-line experiments indicate that independent validation is still required.
-
Anti Reverse Cap Analog for Reliable Cell Assays
2026-08-25
A scenario-based guide to using Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G (SKU B8175) to improve synthetic mRNA translation workflows that support cell viability, proliferation, and cytotoxicity studies. It connects cap chemistry, IVT optimization, assay controls, and practical product-selection criteria with product data and peer-reviewed evidence.
-
Puromycin aminonucleoside Podocyte Workflows
2026-08-24
Build more reproducible podocyte injury and nephrotic disease experiments with a workflow that connects reagent handling, pH-aware cell assays, renal functional endpoints, and blinded pathology. The article also converts a stage-aware strategy from a prostate cancer chemoprevention study into clearly bounded assay-design lessons without confusing mechanistic evidence across organs.
-
Praeruptorin A: Assay Workflows & Troubleshooting
2026-08-24
Build reproducible inflammation, ferroptosis, cardiomyopathy, and metastasis assays around Praeruptorin A with dose-finding, pathway-level validation, and practical troubleshooting. The workflow separates reference-backed observations from optimization recommendations so researchers can exploit this angular pyranocoumarin compound without overinterpreting multi-target biology.
-
Light-Inducible RNA Release for Regulated Gene Therapy
2026-08-23
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls mammalian translation without requiring a separate effector domain. In mouse models, LIRP enabled reversible, light-dependent regulation of therapeutic transgenes for obesity and retinal neovascular disease, highlighting a potential safety and dosing advantage for gene therapies.
-
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-08-22
Boyle et al. showed that CCR7 and Notch1 form a functional signaling partnership that sustains stem-like behavior in MMTV-PyMT mammary cancer cells. The study links chemokine-receptor activity to Notch pathway activation and supports dual-pathway investigation, while leaving the therapeutic value of this strategy to be tested.
-
CPSIT_0844 Drives IL-6 and IL-8 via TLR2/4
2026-08-21
The reference study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a direct inducer of inflammatory IL-6 and IL-8 production in human monocytes. Its experimental design connects CPSIT_0844 with a TLR2/TLR4–MyD88 axis and downstream JNK, p38, and NF-κB signaling, providing a mechanistic framework for studying psittacosis-associated inflammation.
-
Cy3-dCTP Workflows for Direct DNA Labeling
2026-08-20
Cy3-dCTP enables direct fluorescent incorporation into DNA and cDNA for PCR, Nick Translation, reverse-transcription labeling, and hybridization assays. This practical guide connects reagent selection with workflow design, signal optimization, and the emerging enzyme-accessibility concepts reported in DNA synthesis research.
-
DAF-2 Diacetate for Reliable NO Imaging
2026-08-20
Learn how DAF-2 diacetate, SKU C4210, can strengthen live-cell nitric oxide imaging and complementary cytotoxicity workflows. This scenario-based guide covers probe chemistry, experimental controls, protocol optimization, interpretation, and practical vendor-selection criteria.
-
Concanamycin A: V-ATPase Assay Workflows
2026-08-19
Concanamycin A provides a mechanistically focused way to connect V-ATPase activity with endosomal pH, intracellular trafficking, apoptosis, and tumor-cell invasion. This workflow-centered guide combines cancer assay design with a carefully bounded interpretation of new ceramide-synthase findings from plant immunity research.
-
S1P/S1PR3 Drives Neuronal Apoptosis After ICH
2026-08-19
A 2024 study links S1P receptor 3 to neuronal apoptosis after acute intracerebral hemorrhage through a CCL2/TNF-α and caspase-3-associated mechanism involving PI3K/AKT signaling. By combining a mouse hemorrhage model with S1P-stimulated HT22 neuronal experiments and pharmacological S1PR3 inhibition, the work identifies S1PR3 as a context-dependent target for mechanistic and neuroprotection studies.